Journal Home
Access this journal onSciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.
Search for

Volume 3, Issue 12, Page 9 (December 2008)


View previous. 13 of 31 View next.

Candesartan Does Not Prevent Microalbuminuria

NANCY WALSH (New York Bureau)

PHILADELPHIA — Nearly 5 years of treatment with the angiotensin type 1 receptor blocker candesartan did not provide statistical benefit in the prevention of microalbuminuria in patients with diabetes, according to a new post hoc analysis.

PII: S1558-0164(08)70435-8

doi:10.1016/S1558-0164(08)70435-8


View previous. 13 of 31 View next.